BioAdvance is an early-stage venture capital firm and life sciences investor based in King of Prussia, Pennsylvania, United States. It invests in and supports biotechnology, medical device, digital health, and related life science companies across seed and early growth stages. The firm provides capital alongside strategic and operational guidance to help portfolio companies advance scientific innovation toward commercialization. BioAdvance also engages with institutional partners, research hospitals, and academic institutions to identify and nurture promising life science technologies and teams. Its investment activity spans therapeutics, diagnostics, medical technologies, and health-oriented platforms.